Who will take informed consent? {26a}
Patients are participating in a pragmatic trial in which mPATH™ is delivered as part of usual care and patient data collection for clinical outcomes occurs by retrospective electronic chart review. All patients receive current guideline-recommended care. Therefore, this trial is being conducted under a waiver of patient informed consent. Clinic staff and providers participate in surveys and potentially interviews. No sensitive information is collected from clinic staff or providers. Therefore, this trial is being conducted under a waiver of signed consent. All participating staff and providers receive a study information sheet explaining the purpose of the study, the nature of the data to be collected, and the voluntary nature of their participation.